Biotechnology

St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway

SYDNEY, Sept. 12, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that St Jude Children's Research Hospital has successfully completed the first stage of its ongoing phase I study of Kazia's in...

2019-09-12 21:10 7440

Menarini: Elcin Barker Ergun Group CEO

FLORENCE, Italy, Sept. 12, 2019 /PRNewswire/ -- The Board of Directors has appointed Mrs.Elcin Barker Ergun as CEO of Menarini Group. "Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas," commented Eric C...

2019-09-12 20:38 3817

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, ...

2019-09-12 14:15 2805

deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants

REYKJAVIK, Iceland, Sept. 12, 2019 /PRNewswire/ -- deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank participants. The proje...

2019-09-12 00:25 2528

3SBio's MSCI ESG Rating Upgraded to BBB, Ranking at the Forefront of the Global Biotechnology Industry

SHANGHAI, Sept. 11, 2019 /PRNewswire/ -- According to Morgan Stanley Capital International's (MSCI) latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry. MSCI ESG ratings focus on ESG issues that have a substan...

2019-09-11 16:52 2652

Clarivate Analytics acquires the SequenceBase business to expand its search and analysis capabilities for the life sciences IP market

Derwent, a Clarivate Analytics company and world-leading IP intelligence provider, to offer sequence searching for the fast-growing biologics market. LONDON and PHILADELPHIA, Sept. 9, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC;CCC.WS), a global leader in providing trusted insights and...

2019-09-09 19:00 13701

EW Nutrition, Awarded the 2019 Outstanding Contribution Award for Reducing Antibiotic Resistance in the Layer Industry

- Picture is available at AP Images (http://www.apimages.com ) - GUANGZHOU, China, Sept. 9, 2019 /PRNewswire/ -- On August 28-29, the BBS & Excellent Product Award Ceremony for Reducing Antibiotic Resistance for the Layer Industry was held inGuangzhou. China's Ministr...

2019-09-09 18:28 2728

Newly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For 'Complete Clearance' of Symptoms and Consider Combination Therapy For Severe Patients

LAUSANNE, Switzerland, Sept. 9, 2019 /PRNewswire/ -- Published online in the British Journal of Dermatology , updated global recommendations from the ROSacea COnsensus (ROSCO) expert panel call on dermatologists to recognize the importance o...

2019-09-09 16:12 2847

Occlutech AFR Heart Failure Device Obtains CE Mark Approval

SCHAFFHAUSEN, Switzerland, Sept. 6, 2019 /PRNewswire/ -- Occlutech AG announced today that its atrial flow regulator, the Occlutech AFR device, has obtained CE mark approval clearing it for sales on the European CE regulated market. Occlutech AFR is a next generation intra-atrial shunt device, in...

2019-09-06 18:15 2658

Winners Of The 2020 Breakthrough Prize In Life Sciences, Fundamental Physics And Mathematics Announced

SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- The Breakthrough Prize Foundation and its founding sponsors –Sergey Brin, Priscilla Chan and Mark Zuckerberg, Ma Huateng,Yuri and Julia Milner, and Anne Wojcicki – today announced the recipients of the 2020 Breakthrough Prize and 2020 New Horizons Priz...

2019-09-05 23:00 3549

Berkeley Lights Opens Shanghai Location

- Nobel Laureate, Professor James E. Rothman, PhD, to speak at all-day symposium onSeptember 5th - China Rep Office located in one of China's leading high-tech industry clusters SHANGHAI and EMERYVILLE, California, Sept. 5, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader ...

2019-09-05 08:06 2035

CROMSOURCE Continues US Growth With New Office in Research Triangle Park

CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office inCary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two ...

2019-09-04 21:00 1766

IDTechEx Research: The Future of Wearables is Medical

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Wearable technology and medical devices have many prominent synergies. Electronic devices on the body are perfectly placed for sensors to collect data relevant to healthcare, with communication options allowing them to be the gateway to digital health data. C...

2019-09-04 10:00 3959

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery

SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster. DELigh...

2019-09-04 08:00 1809

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

LAVAL, France, Sept. 4, 2019 /PRNewswire/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space.     The expansion integrates Porsolt's new areas of...

2019-09-04 00:03 2329

Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe

BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a clinical stage biopharmaceutical company, announced today that it has successfully closed a Series A financing round totalingCHF 2.82 Million from private investors. These funds will enable ...

2019-09-03 14:00 2967

International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk

MILAN and BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, accordin...

2019-09-03 07:44 3291

Syntellix Asia and Chunli Agree Far-reaching Co-operation to Introduce and Market Innovative "Quantum Leap in Implantology" MAGNEZIX® Medtech Devices in China

- Milestone contract signed between leading Chinese orthopaedic medtech supplier andSingapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery - Contract volume of more than 100 mi...

2019-08-30 22:28 2662

DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds

NEW YORK, Aug. 30, 2019 /PRNewswire/ -- DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation ("Celgene") to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and ...

2019-08-30 01:59 3235

Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India

WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam,In...

2019-08-29 20:04 2750
1 ... 271272273274275276277 ... 281